Oct 05, 2020 / NTS GMT
Unidentified Company Representative
Thanks again for joining the Antisense Therapeutics investor webinar. (Conference Instructions) Presenting on behalf of antisense therapeutics today, we have the MD and CEO, Mark Diamond; Director of Clinical and Regulatory Affairs, Nuket Desem; Director of Drug Discovery, Dr. George Tachas; and the company's US-based Medical Director, Dr. Gil Price. The presentation today will last for approximately 20 minutes with approximately 10 minutes thereafter for the Q&A session. Bear with me while I bring up the presentation and then I'll hand over to Mark to kick-off. Mark, go ahead.
Mark Diamond - Antisense Therapeutics Limited - MD & CEO
Thanks, Matt. And good morning, everyone, and good evening to those joining us on the call from the northern hemisphere. And thank you all for attending today's investor webinar. It has been a very lively and highly rewarding period for the team at Antisense Therapeutics, culminating into our very significant announcements this week.
Matt, could you move to slide 3 there in the presentation?
Antisense Therapeutics Ltd Investor Webinar Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot